Crossref
HER2 ‐targeting zongertinib shows early activity in untreated advanced HER2 ‐mutant NSCLC
Cancer · 01.08.2026 · 132 (15)
DOI: 10.1002/cncr.70489 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 27.07.2026. Verfasst von Leah Lawrence. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lawrence, L. (2026). HER2 ‐targeting zongertinib shows early activity in untreated advanced HER2 ‐mutant NSCLC. Cancer, 132(15). https://doi.org/10.1002/cncr.70489
Vancouver
Lawrence L. HER2 ‐targeting zongertinib shows early activity in untreated advanced HER2 ‐mutant NSCLC. Cancer. 2026;132(15). doi:10.1002/cncr.70489
BibTeX
@article{Lawrence2026,
author = {Lawrence, Leah},
title = {HER2 ‐targeting zongertinib shows early activity in untreated advanced HER2 ‐mutant NSCLC},
journal = {Cancer},
year = {2026},
volume = {132},
number = {15},
doi = {10.1002/cncr.70489}
}
EUVIMED